| Product Code: ETC6736334 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Alzheimers Disease Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Alzheimers Disease Market Revenues & Volume, 2021 & 2031F |
3.3 China Alzheimers Disease Market - Industry Life Cycle |
3.4 China Alzheimers Disease Market - Porter's Five Forces |
3.5 China Alzheimers Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Alzheimers Disease Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.7 China Alzheimers Disease Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.8 China Alzheimers Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 China Alzheimers Disease Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 China Alzheimers Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Alzheimers Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in China |
4.2.2 Growing awareness about Alzheimer's disease and related healthcare services |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 High cost of Alzheimer's disease treatment and care |
4.3.2 Stigma associated with mental health issues in Chinese society |
4.3.3 Limited availability of specialized healthcare professionals for Alzheimer's patients |
5 China Alzheimers Disease Market Trends |
6 China Alzheimers Disease Market, By Types |
6.1 China Alzheimers Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Alzheimers Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Alzheimers Disease Market Revenues & Volume, By Early-onset Alzheimer's, 2021- 2031F |
6.1.4 China Alzheimers Disease Market Revenues & Volume, By Late-onset Alzheimer's, 2021- 2031F |
6.1.5 China Alzheimers Disease Market Revenues & Volume, By Familial Alzheimer's disease, 2021- 2031F |
6.2 China Alzheimers Disease Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 China Alzheimers Disease Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.2.3 China Alzheimers Disease Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F |
6.2.4 China Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Alzheimers Disease Market, By Diagnostics |
6.3.1 Overview and Analysis |
6.3.2 China Alzheimers Disease Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.3.3 China Alzheimers Disease Market Revenues & Volume, By Lumbar Puncture Test, 2021- 2031F |
6.3.4 China Alzheimers Disease Market Revenues & Volume, By Electroencephalography, 2021- 2031F |
6.3.5 China Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Alzheimers Disease Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Alzheimers Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 China Alzheimers Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 China Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Alzheimers Disease Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 China Alzheimers Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Alzheimers Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 China Alzheimers Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 China Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Alzheimers Disease Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Alzheimers Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 China Alzheimers Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 China Alzheimers Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 China Alzheimers Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 China Alzheimers Disease Market Import-Export Trade Statistics |
7.1 China Alzheimers Disease Market Export to Major Countries |
7.2 China Alzheimers Disease Market Imports from Major Countries |
8 China Alzheimers Disease Market Key Performance Indicators |
8.1 Number of government-funded programs for Alzheimer's disease awareness and research |
8.2 Percentage increase in healthcare expenditure for Alzheimer's disease treatment |
8.3 Number of Alzheimer's disease support groups and advocacy organizations in China |
9 China Alzheimers Disease Market - Opportunity Assessment |
9.1 China Alzheimers Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Alzheimers Disease Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.3 China Alzheimers Disease Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.4 China Alzheimers Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 China Alzheimers Disease Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 China Alzheimers Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Alzheimers Disease Market - Competitive Landscape |
10.1 China Alzheimers Disease Market Revenue Share, By Companies, 2024 |
10.2 China Alzheimers Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here